Although discount cards can help alleviate the burden of significant drug expenses from the short-term, they do not deal with the systemic difficulties driving up prescription price ranges inside the U.S. Broader policy variations could tackle the foundation causes of climbing drug costs, for example deficiency of transparency in pricing as well as